Keith Tapper Score: 29
Analyst at
Pivotal Research,
BMO Capital
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+14.4%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
67%
4 W / 2 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
3 W / 3 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 6 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 6 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
60%
3 W / 2 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
60%
3 W / 2 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
1 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 23, 2026 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$14.00
Est. +108%
|
$6.73 | $7.11 |
Pending
|
$6.53
-3.0%
|
| Apr 14, 2025 |
Neurogene Inc
NGNE
|
BUY |
$16.00
Est. +47%
|
$10.89 | $37.06 |
Target Met
|
$35.34
+224.5%
|
| Nov 19, 2024 |
Neurogene Inc
NGNE
|
BUY |
$45.00
Est. +26%
|
$35.59 | $37.06 |
Miss
|
$35.34
-0.7%
|
| Nov 12, 2024 |
Neurogene Inc
NGNE
|
SELL |
$60.00
Est. +7%
|
$64.48 | $6.88 (Low) |
Target Met
|
$35.34
+45.2%
|
| Aug 14, 2024 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$5.00
Est. +116%
|
$2.31 | $3.31 |
Miss
|
$6.53
+182.7%
|
| Jun 26, 2024 |
Acadia Pharmaceuticals Inc
ACAD
|
BUY |
$31.00
Est. +100%
|
$15.50 | $25.23 |
Miss
|
$25.97
+67.5%
|
| Jun 26, 2024 |
Neurogene Inc
NGNE
|
BUY |
$65.00
Est. +103%
|
$32.01 | $74.49 |
Target Met
|
$35.34
+10.4%
|
Taysha Gene Therapies Inc
TSHA
Jun 23, 2026
Signal & Target
BUY
$14.00
Start Price
$6.73
Best Price (1Y)
$7.11
Current Price
$6.53
Return
-3.0%
Neurogene Inc
NGNE
Apr 14, 2025
Signal & Target
BUY
$16.00
Start Price
$10.89
Best Price (1Y)
$37.06
Current Price
$35.34
Return
+224.5%
Neurogene Inc
NGNE
Nov 19, 2024
Signal & Target
BUY
$45.00
Start Price
$35.59
Best Price (1Y)
$37.06
Current Price
$35.34
Return
-0.7%
Neurogene Inc
NGNE
Nov 12, 2024
Signal & Target
SELL
$60.00
Start Price
$64.48
Best Price (1Y)
$6.88
Current Price
$35.34
Return
+45.2%
Taysha Gene Therapies Inc
TSHA
Aug 14, 2024
Signal & Target
BUY
$5.00
Start Price
$2.31
Best Price (1Y)
$3.31
Current Price
$6.53
Return
+182.7%
Acadia Pharmaceuticals Inc
ACAD
Jun 26, 2024
Signal & Target
BUY
$31.00
Start Price
$15.50
Best Price (1Y)
$25.23
Current Price
$25.97
Return
+67.5%
Neurogene Inc
NGNE
Jun 26, 2024
Signal & Target
BUY
$65.00
Start Price
$32.01
Best Price (1Y)
$74.49
Current Price
$35.34
Return
+10.4%